Slide 1: Innovating Healthcare: Top Modalities in Pharma Development. Slide 2: Agenda. Slide 3: The Evolving Pharma Landscape. Slide 4: What are Pharmaceutical Modalities?. Slide 5: Traditional Pillars: Small Molecules. Slide 6: Traditional Pillars: Biologics. Slide 7: Emerging & Advanced Modalities. Slide 8: Nucleic Acid-Based Therapies. Slide 9: mRNA Therapies. Slide 10: siRNA and Antisense Oligonucleotides (ASOs). Slide 11: Gene Therapy. Slide 12: Cell Therapies. Slide 13: CAR-T Cell Therapy. Slide 14: Stem Cell Therapy. Slide 15: Peptide Therapies. Slide 16: Antibody-Drug Conjugates (ADCs). Slide 17: CRISPR/Cas Gene Editing. Slide 18: Phage Display and Library Screening. Slide 19: Enabling Technologies. Slide 20: AI and Machine Learning in Drug Discovery. Slide 21: High-Throughput Screening (HTS). Slide 22: Organ-on-a-Chip and Microfluidics. Slide 23: Advanced Imaging and Omics Technologies. Slide 24: Challenges in Modality Development. Slide 25: Combination Therapies. Slide 26: Personalized Medicine & Companion Diagnostics. Slide 27: Manufacturing & Supply Chain. Slide 28: Regulatory Landscape. Slide 29: Investment Trends. Slide 30: The Convergence of Modalities. Slide 31: Future Outlook. Slide 32: Key Takeaways. Slide 33: The Promise of Innovation. Slide 34: Thank You